Modeling in Therapy
Models of Health Promotion and Illness Prevention II
Clearance Models: Noncompartmental Models
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Autoimmune Disorders
Rheumatic Heart Disease III: Medical Management
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 4, 2026

Minimal Erythema Dose MED Testing
Published on: May 28, 2013
Christopher H Jackson1, Li Su1, Dafna D Gladman2
1MRC Biostatistics Unit, Cambridge Institute of Public Health, Cambridge University, Cambridge, UK.
Statistical modeling of minimal disease activity (MDA) using intermittent clinic data is explored. Hidden model methodology offers more precise estimates of MDA duration and probability compared to complete case analysis, reducing bias.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: